Literature DB >> 21823052

Physical training increases osteoprotegerin in postmenopausal women.

Ingrid Bergström1, Paolo Parini, Sven A Gustafsson, Göran Andersson, Jonas Brinck.   

Abstract

The purpose of this study was to explore whether mechanical loading by exercise over a 1-year period in postmenopausal women had an effect on the receptor activator for nuclear factor kappa B ligand/osteoprotegerin (RANKL/OPG) system or the levels of the Wnt-signaling antagonist sclerostin. A total of 112 postmenopausal were randomized to either sedentary life (controls) or physical activity (training group). Ninety-two women fulfilled the study protocol. The training program consisted of three fast 30-min walks and one or two 1-h aerobic training sessions per week. The effect on the bone mineral density of the hip assessed with dual X-ray absorptiometry was positive as reported earlier. Blood samples were taken from participants at baseline and after 1 year and serum levels of OPG, RANKL and sclerostin were quantified together with the bone metabolism markers C-terminal telopeptide of collagen type I (CTX) and bone-specific alkaline phosphatase (BALP). The results were analyzed using an analysis of covariance model using baseline values as the covariate. The training group displayed a clear mean increase of OPG +7.55 pg/ml compared to controls (p = 0.007). The mean changes for RANKL +0.19 pg/ml (square-root transformed data) and sclerostin +0.62 pmol/l were non-significant (p = 0.13 and p = 0.34). The changes in bone turnover markers CTX and BALP showed a tendency to decrease in the training group versus controls but the changes were small and non-significant. Although our study is limited in number of participating women, we have been able to show an OPG-associated, and RANKL- and sclerostin-independent, training-induced inhibition of postmenopausal bone loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21823052     DOI: 10.1007/s00774-011-0304-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  24 in total

1.  Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading.

Authors:  Lidan You; Sara Temiyasathit; Peling Lee; Chi Hyun Kim; Padmaja Tummala; Wei Yao; Wade Kingery; Amanda M Malone; Ronald Y Kwon; Christopher R Jacobs
Journal:  Bone       Date:  2007-09-26       Impact factor: 4.398

Review 2.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

3.  Physical training preserves bone mineral density in postmenopausal women with forearm fractures and low bone mineral density.

Authors:  I Bergström; Bm Landgren; J Brinck; B Freyschuss
Journal:  Osteoporos Int       Date:  2007-09-01       Impact factor: 4.507

Review 4.  The osteocyte lineage.

Authors:  Brendon S Noble
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

5.  Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.

Authors:  Akinori Kusumi; Hirotaka Sakaki; Tomomi Kusumi; Mitsuo Oda; Kenji Narita; Hiroshi Nakagawa; Kohsei Kubota; Hisashi Satoh; Hiroto Kimura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.

Authors:  M M Saunders; A F Taylor; C Du; Z Zhou; V D Pellegrini; H J Donahue
Journal:  J Biomech       Date:  2005-06-13       Impact factor: 2.712

Review 7.  Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading.

Authors:  Joanna S Price; Toshihiro Sugiyama; Gabriel L Galea; Lee B Meakin; Andrew Sunters; Lance E Lanyon
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

Review 8.  CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.

Authors:  Damaris Vega; Naim M Maalouf; Khashayar Sakhaee
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

9.  Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.

Authors:  Elizabeth J Samelson; Kerry E Broe; Serkalem Demissie; Thomas J Beck; David Karasik; Sekar Kathiresan; Douglas P Kiel
Journal:  J Clin Endocrinol Metab       Date:  2008-02-26       Impact factor: 5.958

10.  Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.

Authors:  Alexander G Robling; Paul J Niziolek; Lee A Baldridge; Keith W Condon; Matthew R Allen; Imranul Alam; Sara M Mantila; Jelica Gluhak-Heinrich; Teresita M Bellido; Stephen E Harris; Charles H Turner
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

View more
  18 in total

Review 1.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

2.  Influence of Mechanical Force on Bone Matrix Proteins in Ovariectomised Mice and Osteoblast-like MC3T3-E1 Cells.

Authors:  Meng Zhang; Shintaro Ishikawa; Tomoko Inagawa; Hideshi Ikemoto; Shiyu Guo; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

3.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

4.  Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

Authors:  Reina Armamento-Villareal; Corinn Sadler; Nicola Napoli; Krupa Shah; Suresh Chode; David R Sinacore; Clifford Qualls; Dennis T Villareal
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 5.  Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.

Authors:  Diogo V Leal; Aníbal Ferreira; Emma L Watson; Kenneth R Wilund; João L Viana
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

6.  Radon balneotherapy and physical activity for osteoporosis prevention: a randomized, placebo-controlled intervention study.

Authors:  Martina Winklmayr; Christian Kluge; Wolfgang Winklmayr; Helmut Küchenhoff; Martina Steiner; Markus Ritter; Arnulf Hartl
Journal:  Radiat Environ Biophys       Date:  2014-10-02       Impact factor: 1.925

Review 7.  Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.

Authors:  Silvia Pieralice; Francesca Vigevano; Rossella Del Toro; Nicola Napoli; Ernesto Maddaloni
Journal:  Curr Diab Rep       Date:  2018-08-18       Impact factor: 4.810

8.  Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.

Authors:  P K Fazeli; K E Ackerman; L Pierce; G Guereca; M Bouxsein; M Misra
Journal:  Osteoporos Int       Date:  2013-04-12       Impact factor: 4.507

9.  Alleviative Effects of Exercise on Bone Remodeling in Fluorosis Mice.

Authors:  Rui Li; Zeen Gong; Yanghuan Yu; Ruiyan Niu; Shengtai Bian; Zilong Sun
Journal:  Biol Trace Elem Res       Date:  2021-05-03       Impact factor: 3.738

10.  Models of care for osteoporosis: A systematic scoping review of efficacy and implementation characteristics.

Authors:  Alicia R Jones; Madhuni Herath; Peter R Ebeling; Helena Teede; Amanda J Vincent
Journal:  EClinicalMedicine       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.